Home

Saba Capital Management, 10% Owner: abrdn Life Sciences Investors HQL Buy · Filed 24/04/23

Trade details

Type
Insider buy
Amount
$633,869.45
Shares · price
48,203 sh · $13.15 a share
Held after
2,787,195 sh
Trade date
24/04/23
Filed
24/04/23
Days to filing
0 days

First buy since 2023

Insiders buying this week
2 insiders
Holding change
+1.8%

abrdn Life Sciences Investors trades, last 26 weeks

What else happened in abrdn Life Sciences Investors around then

Filed or reported within 30 days of the trade day · 24/03/24~24/05/23

Saba Capital Management's recent trades

  • Saba Capital Management

    BuyMexico Fund

    $25.2K

    Filed 10/01

  • Saba Capital Management

    BuyNew Germany Fund

    $118.4K

    Filed 10/01

  • Saba Capital Management

    BuyNew Germany Fund

    $21.1K

    Filed 10/01

  • Saba Capital Management

    BuyGabelli Healthcare & WellnessRx Trust

    $4,941

    Filed 10/01

  • Saba Capital Management

    SellPimco Dynamic Income Strategy Fund

    $180.9K

    Filed 10/01

Saba Capital Management, 10% Owner — bought $633.9K of abrdn Life Sciences Investors HQL · 48,203 sh @ $13.15 | Whalegun